1. Home
  2. VVPR vs SER Comparison

VVPR vs SER Comparison

Compare VVPR & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VivoPower International PLC

VVPR

VivoPower International PLC

HOLD

Current Price

$2.99

Market Cap

40.2M

Sector

Utilities

ML Signal

HOLD

Logo Serina Therapeutics Inc.

SER

Serina Therapeutics Inc.

HOLD

Current Price

$3.21

Market Cap

42.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VVPR
SER
Founded
2014
2017
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Power Generation
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.2M
42.0M
IPO Year
2016
2018

Fundamental Metrics

Financial Performance
Metric
VVPR
SER
Price
$2.99
$3.21
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$13.00
AVG Volume (30 Days)
312.4K
15.1K
Earning Date
01-01-0001
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$61,000.00
$116,000.00
Revenue This Year
N/A
$134.46
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
281.25
N/A
52 Week Low
$0.62
$3.15
52 Week High
$8.88
$7.92

Technical Indicators

Market Signals
Indicator
VVPR
SER
Relative Strength Index (RSI) 51.57 35.70
Support Level $2.37 $3.14
Resistance Level $2.78 $4.26
Average True Range (ATR) 0.22 0.24
MACD 0.11 -0.02
Stochastic Oscillator 76.84 13.39

Price Performance

Historical Comparison
VVPR
SER

About VVPR VivoPower International PLC

Vivopower International PLC is a sustainable energy solutions B Corporation specializing in electric solutions for customized and ruggedized fleet applications, battery and microgrids, solar, and critical power technology and services. The company's core purpose is to provide turnkey decarbonization solutions that help customers progress toward net-zero carbon status. VivoPower operates across five reportable segments: Electric Vehicles, Sustainable Energy Solutions, Solar Development, Digital Assets, and Corporate Office, with personnel and operations in Australia, the Netherlands, the United Kingdom, the United States, and the Philippines.

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

Share on Social Networks: